CIK 0002010788
- Emerging growth company
EXOZYMES INC.
Sign in to watch- Ticker
- EXOZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 834550057
- Phone
- +1 626-415-1488
- Business address
- 750 ROYAL OAKS DR, MONROVIA, CA, 91016
- Former names
- Invizyne Technologies Inc
- 4 Derivatives Options or other derivatives
- 4 Grant or award Vice President, Research acquired 2,990 shares (grant or award)
- 4 Grant or award Vice President, Development acquired 2,990 shares (grant or award)
- 4 Grant or award Vice President, Finance acquired 3,489 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 1,888 shares at an average $10.78 ($20,345)
- 4 Open-market buy Chief Executive Officer bought 1,984 shares at $11.10 ($22,022)
- 3 Insider Initial Statement of Ownership
- 4 Conversion Vice President, Development acquired 2,344 shares (conversion)
- 4 Conversion 10% owner acquired 122,657 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 2 · 40 filings